SQFTW Insider Trading
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Presidio Property Trust Share Price & Price History
Current Price: $0.03
Price Change: ▲ Price Increase of +0.0001 (0.34%)
As of 12/17/2025 01:32 PM ET
Presidio Property Trust Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/20/2023 | Jack Kendrick Heilbron | CEO | Buy | 10,000 | $0.86 | $8,600.00 | 327,678 | |
| 6/15/2023 | Jack Kendrick Heilbron | CEO | Buy | 700 | $9.27 | $6,489.00 | 317,678 | |
| 5/18/2023 | Jack Kendrick Heilbron | CEO | Buy | 2,800 | $0.79 | $2,212.00 | 317,378 | |
| 5/16/2023 | Jack Kendrick Heilbron | CEO | Buy | 100 | $15.21 | $1,521.00 | 2,200 | |
| 12/22/2022 | Jack Kendrick Heilbron | CEO | Buy | 793 | $0.92 | $729.56 | 314,578 | |
| 12/19/2022 | Jack Kendrick Heilbron | CEO | Buy | 9,300 | $0.98 | $9,114.00 | 313,785 | |
| 12/16/2022 | Jack Kendrick Heilbron | CEO | Buy | 4,000 | $1.01 | $4,040.00 | 304,485 | |
SEC Filings (Institutional Ownership Changes) for Presidio Property Trust (NASDAQ:SQFTW)
Presidio Property Trust Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/13/2024 | Armistice Capital LLC | 2,000,000 | $0.12M | 0.0% | N/A | 0.000% |  |
Data available starting January 2016
Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.
Read More on Presidio Property Trust
Volume
6,125 shs
Average Volume
23,177 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A